Denevir Research

Denevir Research is a biotechnology company dedicated to the discovery and development of broad-spectrum antiviral therapies. The company focuses on targeting viroporins, which are ion channel proteins essential for the replication and pathogenesis of various viruses, including SARS-CoV-2 and Influenza. By utilizing a proprietary platform that combines computational modeling with high-throughput screening, Denevir identifies small molecule inhibitors designed to block these viral channels. Their approach aims to provide a robust defense against a wide range of viral infections and potential future pandemics by targeting highly conserved viral structures.